skip to Main Content

Our People

Our dedicated team of experts bring a wide range of knowledge and depth of understanding to the sector.

Berkeley
Greenwood
Senior Partner
Berkeley
Greenwood

Senior Partner

Berkeley has nearly three decades of experience in advising organisations at national and international level. A specialist in market access and external affairs in the life sciences sector, Berkeley has been involved in hundreds of health technology assessments and commissioning decisions (including nearly 30 NICE appeals). He provides training and senior counsel to a number of high-profile organisations and individuals, providing perspective and strategic oversight. As one of Newmarket Strategy’s senior partners, Berkeley oversees the management of the company’s clients and provides support and guidance to its staff. Prior to founding Newmarket Strategy, Berkeley enjoyed a varied career in market access, political consultancy and issues management.

Ed
Jones
Senior Partner
Ed
Jones

Senior Partner

A leading UK health policy expert, Ed has advised at the highest level within government, NHS bodies and healthcare providers. He was the longest ever serving Special Adviser at the UK Department of Health & Social Care, serving as policy adviser to the Health Secretary from 2013-2018. In this time Ed worked under two Prime Ministers and completed Yale University’s System Leadership Programme for NHS leaders.
Ed then moved to the UK Foreign Office as Chief of Staff to the then Foreign Secretary, Jeremy Hunt MP, before going back to the private sector and consultancy in 2019. In 2020 he returned as a senior adviser to NHS England & Improvement on its early response to COVID-19, including the NHS’s nationally commissioned support from independent healthcare providers. Ed now advises a global investment bank, major private equity investors, international medical device companies and health technology suppliers on market access, regulation and commercial strategy.

James
O’Shaughnessy
Senior Partner
James
O’Shaughnessy

Senior Partner

James is one of the UK's leading policy advisors. He has operated at the highest levels of government, including as a Minister at the Department for Health & Social Care, as Director of the No.10 Policy Unit, and as an advisor to DHSC Ministers during the COVID-19 crisis. James is driven by the twin passions of bringing life-changing health innovations to patients and growing the UK’s life science & healthtech industries. As Minister his responsibilities included implementing the Life Science Industrial Strategy, delivering a new pricing scheme with the pharmaceutical industry, chairing the National Genomics Board, and driving the digital transformation of the NHS. He was also responsible for preparing the health and social care sectors for Brexit and helping to design the post-Brexit regulatory regime. James provides senior counsel to multinationals, SMEs, investors, universities and charities across health and life sciences, with a particular focus on technology, digital and data. He is also a Visiting Professor at the Institute of Global Health Innovation where he chairs the Data, Health & Wealth programme. Outside of health, James chairs the Repairing our Social Fabric programme at the think tank Onward, is a Member of the House of Lords, and has a keen interest in education reform.

Blake
Dark
Senior Partner
Blake
Dark

Senior Partner

Blake is a globally connected commercial expert in pharma and health technologies. Until November 2022, Blake was the NHS’s chief negotiator with the pharmaceutical industry and was Interim Chief Commercial Officer and member of NHS England’s Executive Committee.

Blake led successful negotiations securing high-profile commercial deals for cutting-edge new medicines including three gene therapies, multiple oncology products and personalised medicines. He created and implemented the Commercial Framework for New Medicines and Innovative Medicines Fund to stand alongside the Cancer Drugs Fund. He delivered first of a kind innovative procurements for NHS patients such as Hepatitis C, AMR subscription model, GRAIL agreement and Inclisiran population health programmes in the UK.

Prior to joining the NHS, Blake held senior roles in the pharmaceutical industry for 25 years at Sanofi. Blake was Head of Global Commercial Operations for Sanofi’s generics company, and managed Sanofi branded innovative businesses across multiple European countries. Blake’s passion is that commercial activity is fundamental to support patient access to innovative and the most clinically effective healthcare treatments/solutions.

Claudia
Rubin
Senior Director - Value & Access
Claudia
Rubin

Senior Director - Value & Access

Claudia has over a decade of experience helping healthcare and life science organisations to navigate the NHS. A specialist in strategic planning and market access, Claudia has been involved in numerous companies’ commercial and external engagement activities. With her combined knowledge of the healthcare policy environment and the challenging pathways to product reimbursement for medicines and digital technology, Claudia furnishes organisations with useful expert insight. Claudia is also responsible for the overall management of the Newmarket team, leading on ensuring all staff are trained and supported to deliver a consistently high standard of performance across all our work. Outside of work, Claudia can be found exploring the countryside with her family.

Paul
Blakeley
Director - Strategic Government Affairs
Paul
Blakeley

Director - Strategic Government Affairs

Paul has deep expertise in health and life sciences policy, from early-stage research and development, through to market access, adoption and spread of innovation. He was previously the lead for life sciences policy at the Tony Blair Institute for Global Change and has 10 years experience working within UK government.

At TBI, he was instrumental in setting out the institute's vision for the future of UK health and care, including the role technology can play in reforming the NHS and personalising care. He has also co-authored the UK's vision for the future of clinical research delivery and worked with a range of governments to embed and grow their domestic life science sectors.

Paul is a regular speaker at health and life sciences conferences, was a member of the NICE Methods Review working group and has advised senior political figures on the future of UK health and life sciences.

Ele
Harwich
Director - Digital Health and Research
Ele
Harwich

Director - Digital Health and Research

Eleonora has deep expertise in digital health particularly on cutting edge technologies, like artificial intelligence, and regulation. She was previously Head of Collaborations at the NHS AI Lab and was instrumental in leading the G7’s working group on AI in healthcare. During her time at the Lab, she was responsible for the successful publication of two key reports on the evaluation of AI-enabled medical devices, and ways to develop and deploy AI-enabled medical devices across jurisdictions. She was also one of the authors the Lab’s open source AI Dictionary.

Prior to joining the NHS Transformation Directorate, she was Director of Research at Reform think tank, where she co-authored papers on AI in the NHS, the value of healthcare data, commercial models in healthcare and the regulation of data-driven technologies.

She is a member of the British Standards Institution and has sat on a few standards committees, most currently on the safe and ethical use of artificial intelligence in healthcare committee (BS30440). She is also part of One HealthTech, a grassroots community which seeks to promote diversity in healthtech.

David
Reith
Director – Healthcare Services
David
Reith

Director – Healthcare Services

David joined Newmarket Strategy in March 2023 after more than a decade of senior roles within the NHS. Having worked across both acute and commissioning organisations, David has extensive knowledge of healthcare policy, contracting and funding arrangements. He has in-depth understanding of the development and execution of strategic plans, and has significant experience in developing partnerships between the NHS and the independent sector. David is a visiting lecturer at King’s College London, and enjoys working with others who share a passion for transforming and improving healthcare services.

Matthew
Robinson
Senior Manager
Matthew
Robinson

Senior Manager

Matthew joined Newmarket Strategy in January 2024 after several years working in health technology strategy in the NHS. He graduated with a MSci in Neuroscience from the University of Manchester and was then accepted onto the NHS Graduate Management Training Scheme where he specialised in Policy and Strategy. During the programme he gained a postgraduate diploma in Health Policy from Imperial College London.

He then worked in the Innovation, Research and Life Sciences Group at NHS England, working on strategy to increase the adoption and spread of health technologies in the NHS. He then worked as a Senior Strategy Advisor at King’s College London NHS Foundation Trust, supporting their innovation and EDI programmes.

Outside of work, Matt enjoys cycling, running, hill walking and going to the theatre.

 

Thomas
Sheridan
Senior Manager
Thomas
Sheridan

Senior Manager

Tommie joined Newmarket Strategy in May 2024 after several years working on healthcare policy and strategy within the NHS and UK Government.  He has led multiple strategic initiatives alongside industry partners to enhance patient access to innovative healthcare, including the UK's first MedTech strategy and implementation of Community Diagnostic Centres. Tommie has direct operational and policy experience across multiple areas including supply chain management, mental health transformation, and EU healthcare relations. This experience is underpinned by an MSc in Health Policy from Imperial College London, and research in international health systems.

Cristina
Ruiz de Villa
Manager
Cristina
Ruiz de Villa

Manager

Cristina is a Manager at Newmarket Strategy and has a background in market access for medicines and digital devices. She has provided support to clients in a number of market access and health policy projects, and is knowledgeable of the changing reimbursement and access landscape in the UK. She has a particular interest in digital, and is very familiar with the cultural, regulatory and policy barriers to innovation uptake in the NHS. She was the research lead and co-author of the Mental Health Tech Landscape Review and the Learning Disability Tech Landscape Review which made recommendations to policymakers on fostering digital innovation. She also participated in public roundtables to discuss the report findings.

Humoon
Afsardeir
Senior Consultant
Humoon
Afsardeir

Senior Consultant

Humoon graduated with a Bachelor’s degree in Biomedical Sciences and then a Master’s degree in Drug Discovery and Pharma Management from University College London, where he developed an understanding of therapeutic pipelines and the structure of the pharmaceutical industry. Alongside his time in education, he has further developed his research and analytical skills in national and international funded scientific projects in various disease areas. Outside of work, Humoon enjoys keeping healthy through sport and experiencing new cultures by traveling around the world.

Rachel
Barr-Keenan
Senior Consultant
Rachel
Barr-Keenan

Senior Consultant

Rachel joined Newmarket Strategy after four years as an Oral and Maxillofacial Surgery Clinical Fellow across various hospital trusts. She obtained a Bachelor of Dental Surgery with Honours, before spending time at the University of Oxford reading Medicine. Rachel has presented at international conferences, published research and completed post-graduate exams to join the Royal College of Physicians and Surgeons. Rachel is passionate about advancing and improving healthcare services, using her clinical expertise to identify opportunities for innovation adoption. In her spare time, Rachel enjoys exploring the countryside and hiking.

Nooran
Dhillon
Senior Consultant
Nooran
Dhillon

Senior Consultant

Nooran joins Newmarket Strategy with experience in Consulting supporting pharmaceutical clients in Commercial Strategy across different therapeutic areas. During this time, Nooran helped to build launch plans in Rare Oncology and Infectious Diseases, led on competitive intelligence and supported with message testing exercises within Neurology. With experience as a Project Manager at the Royal College of Psychiatrists, Nooran is passionate about improving outcomes for patients and driving innovations to address unmet needs. In her spare time Nooran can be found practicing Yoga and attempting to meditate.

Edward
Irven
Senior Consultant
Edward
Irven

Senior Consultant

Edward graduated with a BA in Sociology from the University of Newcastle, before going on to complete an MSc in Global Health Policy at the London School of Economics. Here he acquired a broad understanding of health policy mechanisms and economic structures, whilst also developing his skills in research and analysis. Alongside this, his academic interests have driven him to complete a Business Analytics course with Harvard Business School and an Epidemiology course with Imperial College London. Outside of work, Edward enjoys travelling with friends and exploring national parks.

Jane
Mullaney
Consultant
Jane
Mullaney

Consultant

Jane joined Newmarket Strategy as Strategic Government Affairs consultant with a postgraduate degree in History from Oxford University and a year of health consultancy experience, where she worked with clients to deliver on communication and policy-related objectives. With a comprehensive understanding of the UK's health landscape and government affairs, she excels in research and client management across diverse disease therapy areas.

Jane is driven by her commitment to improving patient access to innovative medicines and is enthusiastic about leveraging technology to transform healthcare. She is passionate about supporting clients to achieve their goals and is reliable as a consultant.

Outside of work, Jane can be found exploring a new running trail, watching a live musical performance, and catching up with friends.
William
Knight
Consultant
William
Knight

Consultant

William graduated with an undergraduate degree in philosophy from King's College London and a master's degree in philosophy from the University of Oxford. He has previously worked at Guy's and St. Thomas' as an administrative analyst and has experience in venture capital as part of a health tech team. Having joined Newmarket as an intern, William now works as an analyst, straddling both the services and digital health teams. Outside of the office, William is an ardent supporter of Chelsea Football Club, and he loves to cook.

Eddie
Tan
Consultant
Eddie
Tan

Consultant

Eddie graduated with an MSc in Biomedical Engineering from Imperial College London and a BEng in Biomedical Engineering from Queen Mary University of London. After graduating, Eddie worked as a Research Analyst where he supported a range of Health Technology SMEs to access the UK Market by providing Business Support focussing on Market Understanding, Competitor Analysis, Development of Value Proposition, Market Access, and Partner Searches. He has taken the role as project lead in the research and delivery of several Health Economic Modelling projects in several different clinical areas (e.g., COPD, Cancer, Stroke and Parkinson’s Disease). Eddie is passionate about contributing to the development of Digital Health Technologies.

In his free time, Eddie enjoys playing badminton and tennis as well as a strong interest in Films and TV.

Carol
Moules
Office Manager
Carol
Moules

Office Manager

Carol has worked alongside Berkeley Greenwood for some years in the capacity of Office Manager and has been the focal point of the team. Carol’s role encompasses day to day administration, liaison with clients, supervision of accounting activity, personnel matters, office services, and organising travel and events for colleagues and clients. She has many years’ experience in the marketing and product development field, working for companies with varied top end products and services. Carol spends her free time reading, cooking, gardening and walking and is interested in interior design, art and history.

Jane
Vago
Deputy Office manager
Jane
Vago

Deputy Office manager

Jane joined Newmarket Strategy in November 2022 as vital support to the office management team.  Jane’s role is varied and includes administration, accounting activities, personnel matters, arranging corporate events and any other tasks to ensure the smooth running of the office.

Having raised 3 children and lived in a variety of countries, most recently Italy, Jane is passionate about cooking, choral singing and theatre of all kinds.  Jane particularly enjoys meeting up with friends and travelling.

Jacquelyn
Bell
Executive Assistant
Jacquelyn
Bell

Executive Assistant

Jacquelyn provides administrative support to the senior Newmarket team. Jac has over 20 years of experience providing senior-level business assistance to a wide range of organisations and individuals, primarily in the healthcare sector. At different points in her career, Jac left executive assistant work and gained qualified teacher status, and a degree in Ancient History and Archaeology. Jac is a trustee of a CIO that promotes the advancement of the performing arts and music education, and is herself a writer and classically trained amateur singer.

Isaac
Ezro-Lack
Associate
Isaac
Ezro-Lack

Associate

Isaac joined Newmarket Strategy from NHS England where most recently he led on technology prioritisation for NICE’s Early Value Assessments, as well as other initiatives such as the Health Technology Acceleration and Adoption Fund. Isaac also acted as Head of Office to several Directors at NHS England and the Department of Health and Social Care.  Prior to working at national level, Isaac established the Children and Young People’s Transformation team at Whittington Health, including the co-location of acute paediatric services in North London during the pandemic, and later as an Innovation and Research Fellow.

Isaac also has experience in the private sector where he has worked with IBM on price modelling and exploring the commercialisation of products in the UK and Europe. He has led commercial strategy and partnerships at Arete Medical Technologies for the last 4 years and continues to do so in tandem with his role at Newmarket.

Isaac mentors on accelerator programmes such as the NHS Clinical Entrepreneur Programme and the P4 Precision Medicine accelerator. He is also a founder having established Zenithia, developing healthy games, and is building a community for investment and support for digital health startups.

Outside of work, Isaac enjoys sports, travelling with his wife, and enjoying good food and wine with friends and family.

Sir David
Sloman
Senior Associate
Sir David
Sloman

Senior Associate

Sir David is one of the UK’s most outstanding and influential healthcare leaders, having spent his 40-year career in NHS management and leadership. He was awarded a knighthood in the 2017 New Year's honours list in recognition of his services. Sir David joined the NHS as a management trainee, undertaking various leadership roles including nearly ten years as Chief Executive of the Royal Free London NHS Foundation Trust. Sir David ended his NHS career on the Board of NHS England as its Chief Operating Officer before his retirement in 2023.

Iain
O’Neil
Senior Associate
Iain
O’Neil

Senior Associate

Iain has held senior roles driving digital health in government, the NHS and private sector over 20 years, most recently as Digital Transformation Director at NHSx until the end of 2021.

Having joined the Department of Health and Social Care (DHSC) in 2017, Iain led the development of the digital strategy for DHSC and NHS England, before joining the leadership team of the newly formed NHSx. Iain worked on the development of the NHS App, the transformation of national screening, cancer and mental health services and was the Senior Responsible Officer for the NHS 111 Online service. Through COVID, he worked on the Covid vaccinations service, digitising social care, and led teams that created - amongst other things - the messaging service for the 2.2million clinically vulnerable people and a digital health record system for those transferred from hospital to social care.

Prior to the NHS, Iain spent 15 years in digital and technology transformation roles in the private sector, including four years as digital director at Nuffield Health, where he led the development and launch of their national online gym-joining and class-booking services, as well as digitising care pathways in Nuffield’s private hospitals.

Suzy
Heafield
Senior Associate
Suzy
Heafield

Senior Associate

Suzy is a pharmacist and held senior medicines commissioning roles within NHS England since 2013, most recently as Head of Medicines Value and Delivery within the Commercial Medicines Directorate. Suzy focused on delivering the best value and patient outcomes from the NHS’s medicines budget, which included developing an innovative strategic category management approach to medicines procurement. Projects delivered include the pilot subscription-type payment model for antimicrobials as well as procurements for hepatitis C and HIV treatments. Suzy also managed the NHS Medicines Value Programme, introducing a greater focus on delivery of clinical and financial outcomes.

Suzy was also Chief of Staff to the Commercial Medicines Director, providing strategic, clinical, and professional advice to the team as well as supporting numerous high-profile population health and early access negotiations, ensuring these were transacted into commercial agreements that could effectively be delivered by the NHS.

Dr Keith
Ridge CBE
Senior Associate
Dr Keith
Ridge CBE

Senior Associate

Dr Keith Ridge CBE was the Chief Pharmaceutical Officer for England for nearly twenty years until his recent retirement from the NHS and the pharmaceutical register. As the country’s most senior pharmacist, he led the profession, and was the NHS’s and Government’s principal leader on pharmacy and medicines use. Keith was the professional lead on medicines policy, working alongside national policy directors over many years.  He was the clinical lead for the introduction of biosimilars to the NHS, working closely with both patient representatives and policy makers to secure both better access and value.  Keith introduced medicines optimisation into the NHS, whilst also having responsibility for digital medicines and pharmacy educational reform. He led programmes on transforming pharmacy practice in line with the NHS’s Five Year Forward View and Long Term Plan, including the development of clinical practice in community pharmacy and the introduction of clinical pharmacy into general practice. He also played a senior role in the UK’s antimicrobial resistance and influenza programmes. He was the professional lead for both securing the medicines supply chain and delivering the pharmaceutical aspects of the vaccination programme during Covid and has represented Government nationally and internationally. Keith has also led Government reviews on pharmacy professional regulation, education, medication safety and overprescribing. Prior to his national roles he was a Chief Pharmacist at major UK teaching hospitals.

Kelly
Lin
Senior Associate
Kelly
Lin

Senior Associate

Kelly is an economist with over 15 years of experience in the NHS and private sector delivering evidence-driven strategy and policy programmes. She was most recently a Deputy Director in the Innovation, Research and Life Sciences team in NHS England leading the development of the commercial framework access to NHS data for research and innovation, NHS IP policy and commercial approaches to facilitate the adoption of digital innovation in the NHS. She is passionate about helping to form mutually beneficial partnerships between the NHS and private sector that drive leading-edge innovations and the smooth adoption of new technology that transforms care for patients.

Kelly’s roles in the NHS have included working within hospitals, developing clinical strategy at St George’s Hospital and in helping Barts Health recover elective services as part of their Transformation team. During Covid she was part of the team modelling hospital beds and other resources needed to advise on policy changes to cope with demand. She has advised Ministers on policies to reduce spending on bank and agency staff and led the initial development of the pricing regime for the NHS to drive efficient and effective care delivery.

Prior to joining the NHS Kelly was a strategy consultant at KPMG leading analytical projects for a range of international clients. She started her career in investment banking focused on large M&A transactions primarily in the utilities and infrastructure sectors.

At Newmarket we operate a strict meritocracy where hard work, diligence and results are rewarded. As such there are no limitations on how far or how quickly an outstanding candidate may expect to rise through the company.

We strive to develop long-term employees and the successful applicant can expect to enjoy plentiful opportunities for professional development and career progression.

Read our latest insights

Back To Top